---
layout: post
title: "Sales of LeqembiÂ® totaled 20.7 billion yen in the fourth quarter 2025"
date: 2026-02-06T11:17:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/sales-of-leqembi-totaled-20-7-billion-yen-in-the-fourth-quarter-2025--302681249.html
significance: 9.00
---

<p>STOCKHOLM, Feb. 6, 2026 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today published the preliminary global revenue for Leqembi for the fourth quarter 2025, in conjunction with their partner Biogen's fourth quarter report. In total, sales of JPY 20.7...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/sales-of-leqembi-totaled-20-7-billion-yen-in-the-fourth-quarter-2025--302681249.html)

**Published:** 2026-02-06 11:17:00 +0000

**Significance Score:** 9.00

[View original](https://www.prnewswire.com/news-releases/sales-of-leqembi-totaled-20-7-billion-yen-in-the-fourth-quarter-2025--302681249.html)
